An innovative gene-editing treatment is making waves in the medical community, offering a potential breakthrough in heart disease prevention. This experimental therapy, developed by a company now under Eli Lilly, targets the PCSK9 gene in the liver to dramatically lower LDL cholesterol levels. In a preliminary trial involving 35 patients with genetically high LDL levels or existing heart disease, the highest dose reduced LDL by up to 62%. These reductions have persisted for 18 months in some patients, and a larger study involving 200 participants is planned.
Cardiovascular disease remains a leading cause of death in the United States, claiming nearly 800,000 lives annually. Current treatments, such as daily statin pills and injected PCSK9-blocking drugs, are effective but often face adherence challenges. Many patients discontinue these medications within a year, even after experiencing a heart attack. A one-time gene-editing treatment could eliminate this barrier, making it a game-changer in primary care.
While the potential benefits are significant, experts advise caution. The Food and Drug Administration mandates that all gene therapy patients be monitored for 15 years, emphasizing the need for extensive safety data before widespread use. The affordability of such treatments is also a priority, with the goal of making them accessible to a broad population if approved.
New Insights into Alzheimer’s Disease
Researchers at University Hospitals and Case Western Reserve University have uncovered a new understanding of Alzheimer’s disease, focusing on the role of nitric oxide. Contrary to previous beliefs, the study found that Alzheimer’s patients have lower levels of nitric oxide in their brains, which correlates with increased plaque buildup and faster memory decline. This discovery challenges decades of scientific thinking and suggests that restoring nitric oxide levels could be a potential treatment avenue. The findings, published in Molecular Cell, pave the way for further research, including animal studies using enzyme inhibitors to restore nitric oxide levels.
Supplement Use: Proceed with Caution
The Cleveland Clinic advises individuals to approach supplements with the same caution as medications. Overuse can strain the kidneys and liver and may interact with prescription drugs. Many supplements lack scientific validation and are not regulated by the Food and Drug Administration. Pregnant women, in particular, should consult healthcare providers before taking new supplements, as some can harm a developing baby. Consumers are encouraged to choose third-party-tested products to ensure safety.
Original reporting: WQAD (Quad Cities) — read the source article.
